These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35278294)

  • 1. Bradycardia during optical timolol therapy: its delayed remission after timolol discontinuation and unexpected further relapse.
    Elikowski W; Fertała N; Zawodna-Marszałek M; Gaca-Wysocka M; Bolewski A
    Pol Merkur Lekarski; 2022 Feb; 50(295):25-29. PubMed ID: 35278294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome oxidase 2D6 gene polymorphism in primary open-angle glaucoma with various effects to ophthalmic timolol.
    Yang Y; Wu K; Yuan H; Yu M
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):163-71. PubMed ID: 19284319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.
    Epperla N; Brilliant MH; Vidaillet H
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP2D6 single-nucleotide polymorphism with response to ophthalmic timolol in primary open-angle Glaucoma--a pilot study.
    Yuan H; Yu M; Yang Y; Wu K; Lin X; Li J
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):497-501. PubMed ID: 20925579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma.
    Dickstein K; Hapnes R; Aarsland T
    Am J Ophthalmol; 2001 Nov; 132(5):626-32. PubMed ID: 11704023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of
    Moshetova LK; Soshina MM; Turkina KI; Grishina EA; Sozaeva ZA; Kachanova AA; Akmalova KA; Ivashchenko DV; Zastrozhin MS; Fisenko VP; Sychev DA
    Drug Metab Pers Ther; 2023 Jun; 38(2):143-148. PubMed ID: 36001461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
    Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
    Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular timolol as the causative agent for symptomatic bradycardia in an 89-year-old female.
    Rains J; Kesterson J
    Am J Emerg Med; 2021 Apr; 42():263.e5-263.e6. PubMed ID: 32980226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac failure aggravated by timolol eye drops: preoperative improvement by changing to pilocarpine.
    Bäcklund M; Kirvelă M; Lindgren L
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):379-81. PubMed ID: 8721473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac safety of ophthalmic timolol.
    Mäenpää J; Pelkonen O
    Expert Opin Drug Saf; 2016 Nov; 15(11):1549-1561. PubMed ID: 27534869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradycardia and congestive heart failure associated with ocular timolol maleate.
    Linkewich JA; Herling IM
    Am J Hosp Pharm; 1981 May; 38(5):699-701. PubMed ID: 7282702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bradyarrhythmias secondary to the use of ophthalmic timolol. A report of 3 cases].
    Anguita M; Torres F; Giménez D; Segura J; Aumente D; Suárez de Lezo J; Vallés F
    Rev Esp Cardiol; 1992 Jan; 45(1):71-3. PubMed ID: 1549765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SYNCOPE CAUSED BY INTRA-OCULAR TIMOLOL].
    Eyal A; Braun E; Naffaa ME
    Harefuah; 2015 Nov; 154(11):701-2, 742. PubMed ID: 26821501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial.
    Müller L; Jensen BP; Bachmann LM; Wong D; Wells AP
    Clin Exp Ophthalmol; 2020 Jan; 48(1):24-30. PubMed ID: 31525271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.
    Nordmann JP; Rouland JF; Mertz BP
    Curr Med Res Opin; 1999; 15(2):87-93. PubMed ID: 10494491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the systemic effects of timolol maleate in eye drops].
    Hugues FC; Le Jeunne C; Munera Y; Dufier JL
    J Fr Ophtalmol; 1985; 8(5):389-94. PubMed ID: 4093537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete atrioventricular block due to timolol eye drops: a case report and literature review.
    Wang Z; Denys I; Chen F; Cai L; Wang X; Kapusta DR; Lv Y; Gao J
    BMC Pharmacol Toxicol; 2019 Dec; 20(1):73. PubMed ID: 31791399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.